Term
|
Definition
| cardio, GI, gyne, maintain patent infant DA, urology |
|
|
Term
|
Definition
| cardio, anticoagulant, GI, pulmonary HTN, infant DA, |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| latanoprost, bimatoprost, travoprost |
|
Definition
|
|
Term
|
Definition
| hemostatics: given to decrease bleeding |
|
|
Term
|
Definition
| CHF (inotropes autacoid, BNP analog) |
|
|
Term
|
Definition
| endothelin receptor antagonist |
|
|
Term
|
Definition
| carbonic anhydrase inhibitor (PCT) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
HTN (loop diuretic)
can cause hypokalemia |
|
|
Term
|
Definition
|
|
Term
|
Definition
HTN (thiazide, DCT)
can lead to hypokalemia
|
|
|
Term
|
Definition
Thiazide like Diuretic (DCT)
can cause hypokalemia |
|
|
Term
|
Definition
HTN, CHF (thiazide like DCT)
can cause hypokalemia
10X potent as HCTZ |
|
|
Term
|
Definition
|
|
Term
|
Definition
HTN (thiazide diuretic DCT)
20X potent HCTZ |
|
|
Term
|
Definition
HTN, CHF (DCT, K+ sparing)
aldosterone antagonist |
|
|
Term
|
Definition
| HTN, CHF (DCT K+ sparing aldosterone antagonist) |
|
|
Term
|
Definition
HTN (DCT K+ sparing)
not an aldosterone antagonist |
|
|
Term
|
Definition
HTN (DCT K+ sparing)
not an aldosterone antagonist |
|
|
Term
|
Definition
ADH agonist, collecting duct
binds V1 → vasoconstriction |
|
|
Term
|
Definition
ADH agonist collecting duct
binds V2 → aquaporin channels |
|
|
Term
|
Definition
ADH antagonist, collecting duct
treats SIADH |
|
|
Term
|
Definition
| HTN (centrally α2 agonist) |
|
|
Term
|
Definition
| HTN (centrally α2 agonist) |
|
|
Term
|
Definition
| HTN (centrally α2 agonist) |
|
|
Term
|
Definition
| HTN (inhibits intracellular NE packaging) |
|
|
Term
|
Definition
| HTN (α1, α2 irreversible antagonist) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| HTN, CHF (β1, β2 antagonist) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| HTN (α, β1, β2 antagonist) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
HTN (direct vasodilator via inhibition of ATP K channel)
dilates arteries not veins |
|
|
Term
|
Definition
| HTN (direct vasodilator via opening of K+ channels) |
|
|
Term
|
Definition
| HTN (direct vasodilator via dopaminergic receptors) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
HTN (phenylalkylamine, Ca2+ channel blocker)
acts on peripheral vasculature and heart |
|
|
Term
|
Definition
HTN (dihydropyridine, Ca2+ channel blocker)
acts on peripheral vasculature |
|
|
Term
|
Definition
HTN (dihydropyridine, Ca2+ channel blocker)
Acts mainly on peripheral vasculature |
|
|
Term
|
Definition
HTN (dihydropyridine, Ca2+ channel blocker)
acts on peripheral vasculature |
|
|
Term
|
Definition
HTN (dihydropyridine, Ca2+ channel blocker)
affects only peripheral vasculature |
|
|
Term
|
Definition
HTN (benzothiazepine, Ca2+ channel blocker)
Has effects in peripheral vaculature and on the heart |
|
|
Term
|
Definition
| HTN (diarylaminopropylamine, Ca2+ channel blocker) |
|
|
Term
|
Definition
| HTN, CHF (endothelin receptor blocker) |
|
|
Term
|
Definition
| CHF (digitalis glycoside) |
|
|
Term
|
Definition
| CHF (direct acting vasodilator on arteriolar smooth muscle) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| CHF, HTN (nitrosovasodilator) |
|
|
Term
|
Definition
| CHF (non-glycoside inotrope) |
|
|
Term
|
Definition
CHF (non-glycoside inotrope)
β1 agonist used in end-stage CHF |
|
|
Term
|
Definition
| treats severe HTN associated with preeclampsia (false neurotransmitter) |
|
|
